Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 96Triple Negative Breast Neoplasms 42Breast Neoplasms, Male 18Inflammatory Breast Neoplasms 11Neoplasm Metastasis 8Carcinoma, Non-Small-Cell Lung 7Ovarian Neoplasms 6Lung Neoplasms 5Carcinoma, Ovarian Epithelial 5Stomach Neoplasms 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Esophageal Neoplasms 4Endometrial Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 4Sarcoma 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Urinary Bladder Neoplasms 2Testicular Neoplasms 2Small Cell Lung Carcinoma 2Salivary Gland Neoplasms 2Neoplasms, Unknown Primary 2Neoplasms 2Melanoma 2Lymphoma, Non-Hodgkin 2Breast Carcinoma In Situ 2Anatomic Stage II Breast Cancer AJCC v8 2Uterine Cervical Neoplasms 1Thrombocytosis 1

Interventions

Taxes 1Paclitaxel 1Lapatinib 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Taxes × Breast × Clear all
NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

University of California, San Francisco

Phase 1 Completed
28 enrolled
BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡